Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
105,274,735
-
Total 13F shares
-
84,732,406
-
Share change
-
+1,742,153
-
Total reported value
-
$2,752,093,285
-
Put/Call ratio
-
118%
-
Price per share
-
$32.48
-
Number of holders
-
269
-
Value change
-
+$61,774,959
-
Number of buys
-
126
-
Number of sells
-
118
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) as of Q4 2023
As of 31 Dec 2023,
CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,732,406 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, Novo Holdings A/S, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and Boston Trust Walden Corp.
This page lists
269
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.